Pharmacologic ROMK Inhibition Protects Against Myocardial Ischemia Reperfusion Injury

Area of Science:

• Cardiovascular Science
• Mitochondrial Biology
• Renal Physiology

Background:

• Mitochondrial ATP-sensitive K+ channels are crucial for cardioprotection and potential therapeutic targets for ischemia reperfusion (IR) injury.
• Renal outer medullary K+ channel isoform 2 (ROMK2) is an ATP-sensitive K+ channel in cardiomyocyte mitochondria, but its role in adult myocardial IR injury is unclear.

Purpose of the Study:

• To investigate the effect of ROMK loss of function on adult myocardial IR injury.
• To explore the underlying mechanisms of ROMK's role in cardiac mitochondria.

Main Methods:

• Utilized a selective small molecule inhibitor of ROMK in a murine model.
• Assessed cardiac function and mitochondrial parameters following IR injury.
• Investigated the role of phosphatidylinositol 4,5-bisphosphate (PIP2) in modulating ROMK activity.

Main Results:

• ROMK inhibition paradoxically protected mouse hearts from IR injury compared to controls.
• ROMK inhibition induced exaggerated mitochondrial uncoupling and increased reactive oxygen species (ROS) production.
• PIP2 modulated ATP's effect on mitochondrial membrane potential, and ROMK inhibition increased mitochondrial swelling without ATP.

Conclusions:

• Pharmacologic ROMK inhibition confers cardioprotection against IR injury in mice.
• ROMK inhibition may promote enhanced mitochondrial matrix K+ handling, suggesting a role in K+ efflux.
• Further research is warranted to elucidate ROMK's function in mitochondrial K+ transport and its therapeutic potential for IR injury.